Group comparative trial of 2% nedocromil sodium with placebo in the treatment of seasonal allergic conjunctivitis.
A double blind group comparative trial comparing 2% nedocromil sodium with placebo in treating seasonal allergic conjunctivitis over a four week period is reported. Sixty-four patients were analysed. During the period of peak pollen challenge, statistically significant differences in favour of nedocromil sodium for itching and soreness were demonstrated. During a longer period of a less high pollen count, a significant difference in favour of nedocromil sodium was shown only for the symptom of soreness.
Department of Ophthalmology, Taunton and Somerset Hospital, Bristol, U.K.
A
A
Stockwell
D L
DL
Easty
D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D017835:Nedocromil / Q000008:administration & dosage*; D009883:Ophthalmic Solutions; D010919:Placebos; D011058:Pollen; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D009883:Ophthalmic Solutions; D010919:Placebos; D017835:Nedocromil